This article is part of a special supplement published by Nephrology News & Issues in the February 2014 issue entitled, "Iron therapy and a quarter century of ESAs: What have we learned?" The ...
Vascular Calcification mortality non-dialysis CKD Study shows benefit of initiating epoetin beta therapy at hemoglobin levels not less than 10 g/dL in non-dialysis CKD patients. Earlier treatment of ...
statin-therapy_1115 Using statins for more than 3 months was significantly associated with 85% lower odds of ESA hyporesponsiveness in CKD patients. Statin therapy may curb hyporesponsiveness to ...
Expert panelists discuss when it’s appropriate to consider or continue ESA therapy or blood transfusions in patients with MDS. Bruce Feinberg, DO: Amer, invariably, there are patients who aren’t going ...
THOUSAND OAKS, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will review the results from TREAT (the Trial to Reduce Cardiovascular Events with ...
Renal anaemia is a frequent complication in patients with chronic kidney disease (CKD). Severe anaemia (haemoglobin <90 g/l) is associated with increased risks of mortality and cardiac complications, ...
Please provide your email address to receive an email when new articles are posted on . Patients switched to oral vadadustat had hemoglobin levels similar to those on a long-acting ...
Amgen has finally lost control of the U.S. market for anemia drugs needed to treat dialysis patients. In the middle of the day the FDA announced that it had handed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback